Lindsey Drake
Affiliations: | 2014-2019 | Medicinal Chemistry | University of Michigan, Ann Arbor, Ann Arbor, MI |
Google:
"Lindsey Drake"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Drake LR, Wu Y, Naganawa M, et al. (2024) First-in-Human Study of F-SynVesT-2: An SV2A PET Imaging Probe with Fast Brain Kinetics and High Specific Binding. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Drake LR, Brooks AF, Stauff J, et al. (2020) Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE). Journal of Pharmaceutical Analysis. 10: 452-465 |
| Drake LR, Hillmer AT, Cai Z. (2020) Approaches to PET Imaging of Glioblastoma. Molecules (Basel, Switzerland). 25 |
| Drake LR, Pham JM, Desmond TJ, et al. (2019) Identification of AV-1451 as a Weak, Nonselective Inhibitor of Monoamine Oxidase. Acs Chemical Neuroscience |
| Narayanaswami V, Drake LR, Brooks AF, et al. (2019) Classics in Neuroimaging: Development of PET Tracers for Imaging Monoamine Oxidases. Acs Chemical Neuroscience |
| Brooks AF, Drake LR, Shao X, et al. (2018) Evaluation of Enzyme Substrate Radiotracers as PET/MRS Hybrid Imaging Agents. Acs Medicinal Chemistry Letters. 9: 1140-1143 |
| Drake LR, Brooks AF, Mufarreh AJ, et al. (2018) Deuterium Kinetic Isotope Effect Studies of a Potential In Vivo Metabolic Trapping Agent for Monoamine Oxidase-B. Acs Chemical Neuroscience |
| Cary BP, Brooks AF, Fawaz MV, et al. (2016) Synthesis and Evaluation of [(18)F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts. Acs Chemical Neuroscience |
| Brooks AF, Drake LR, Stewart MN, et al. (2016) Fluorine-18 patents (2009-2015). Part 1: novel radiotracers. Pharmaceutical Patent Analyst. 5: 17-47 |